Global Public Health

Why drug-resistant TB matters to the world


Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.

Learn more about the report here.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.